Barclays’s Smith & Wesson SWBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-36,948
Closed -$236K 6198
2020
Q1
$236K Buy
36,948
+24,719
+202% +$175K ﹤0.01% 4160
2019
Q4
$87K Buy
12,229
+11,839
+3,036% +$72.2K ﹤0.01% 5541
2019
Q3
$2K Sell
390
-13,921
-97% -$84K ﹤0.01% 6549
2019
Q2
$99K Buy
14,311
+5,594
+64% +$39.6K ﹤0.01% 5702
2019
Q1
$63K Sell
8,717
-33,175
-79% -$301K ﹤0.01% 5709
2018
Q4
$414K Sell
41,892
-26,020
-38% -$270K ﹤0.01% 3976
2018
Q3
$811K Buy
67,912
+18,994
+39% +$172K ﹤0.01% 3828
2018
Q2
$452K Sell
48,918
-4,163
-8% -$37.4K ﹤0.01% 4046
2018
Q1
$421K Sell
53,081
-59,195
-53% -$498K ﹤0.01% 4140
2017
Q4
$1.11M Sell
112,276
-11,449
-9% -$124K ﹤0.01% 3018
2017
Q3
$1.45M Buy
123,725
+14,831
+14% +$209K ﹤0.01% 2649
2017
Q2
$1.85M Buy
108,894
+80,012
+277% +$1.38M ﹤0.01% 2329
2017
Q1
$440K Sell
28,882
-95,754
-77% -$1.46M ﹤0.01% 3528
2016
Q4
$2.02M Sell
124,636
-40,071
-24% -$740K ﹤0.01% 2112
2016
Q3
$3.37M Buy
164,707
+58,936
+56% +$1.29M ﹤0.01% 1586
2016
Q2
$2.21M Buy
105,771
+71,685
+210% +$1.28M ﹤0.01% 1929
2016
Q1
$681K Sell
34,086
-23,678
-41% -$441K ﹤0.01% 2863
2015
Q4
$932K Buy
57,764
+13,400
+30% +$197K ﹤0.01% 2679
2015
Q3
$546K Sell
44,364
-31,484
-42% -$411K ﹤0.01% 3277
2015
Q2
$933K Buy
75,848
+49,308
+186% +$569K ﹤0.01% 2936
2015
Q1
$245K Sell
26,540
-7,156
-21% -$68.4K ﹤0.01% 4182
2014
Q4
$233K Sell
33,696
-5,334
-14% -$40K ﹤0.01% 4519
2014
Q3
$270K Sell
39,030
-27,191
-41% -$253K ﹤0.01% 4474
2014
Q2
$713K Sell
66,221
-11,969
-15% -$141K ﹤0.01% 3648
2014
Q1
$841K Buy
78,190
+19,905
+34% +$205K ﹤0.01% 3427
2013
Q4
$582K Sell
58,285
-133,222
-70% -$1.19M ﹤0.01% 3946
2013
Q3
$1.47M Buy
191,507
+73,766
+63% +$638K ﹤0.01% 2924
2013
Q2
$903K Buy
+117,741
New +$820K ﹤0.01% 3510

Other funds holding SWBI

Barclays's SWBI Position: Q1 2026 in Review

Barclays reduced its Smith & Wesson (SWBI) stake by 78% in Q1 2026, selling an estimated $703K and leaving 16,055 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #3604.

Barclays first reported a position in SWBI in Q2 2013 and has held it in 45 quarters since. The position peaked at $5.25M in Q3 2016. 190 funds tracked by Wall St. Rank hold SWBI as of Q1 2026.

  • Barclays held 16,055 shares of Smith & Wesson worth $230K as of Q1 2026.
  • Barclays sold 57,837 Smith & Wesson shares in Q1 2026, an estimated $703K.
  • Smith & Wesson made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3604 holding.
  • Barclays first reported a position in Smith & Wesson in Q2 2013 and has held it in 45 quarters since.
  • Barclays's Smith & Wesson position peaked at $5.25M in Q3 2016.
  • 190 funds tracked by Wall St. Rank held Smith & Wesson as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.